IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Biomark Capital Management Co. LLC

Q2 2016 Holdings

Filed 2016-08-12 | 3 holdings | $77.9K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Juno Therapeutics, Inc.COMMON STOCK48205A109$68.5K2,205,92687.9%
Adma Biologics, Inc.(ADMA)COMMON STOCK000899104$9.3K1,433,30411.9%
Mabvax Therapeutics Holdings, Inc.COMMON STOCK55414P108$119197,6410.2%